News & Blog

Tag Archives: pharmaceutical companies

So You Heard About Rintega? Here’s What’s Next for Brain Tumor Drug Development

Last week, news broke that a promising clinical trial of a new type of treatment for a subset of glioblastoma (GBM) patients – an immunotherapeutic vaccine made by Celldex Therapeutics called RINTEGA (rindopepimut) – was discontinued because patients receiving the investigational therapy were not doing better than patients in the control arm. As we said in our statement regarding […]

Congress Delivers Brain Tumor Community Holiday Gift

More funding for NIH to raise all ships, and specific funding for pediatric brain tumors, is welcome! More money will be available for brain tumor research in 2016, thanks to a year-end budget deal in the United States Congress that was reached today. The “omnibus” spending bill that sets government spending levels and priorities for […]

Brain Tumor Groups Come Together for New Imaging Effort

When an athlete injures their knee, ankle, shoulder, etc. they will often need to go for an “MRI” to determine the extent of the damage done to the affected area. And in most cases the MRI will be able to diagnose the issues with relative ease, accuracy and expediency. Most Americans are familiar with MRIs […]

Share